These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23543592)

  • 1. Global differences in dialysis modality mix: the role of patient characteristics, macroeconomics and renal service indicators.
    van de Luijtgaarden MW; Jager KJ; Stel VS; Kramer A; Cusumano A; Elliott RF; Geue C; MacLeod AM; Stengel B; Covic A; Caskey FJ
    Nephrol Dial Transplant; 2013 May; 28(5):1264-75. PubMed ID: 23543592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A call for harmonization of European kidney care: dialysis reimbursement and distribution of kidney replacement therapies.
    van der Tol A; Stel VS; Jager KJ; Lameire N; Morton RL; Van Biesen W; Vanholder R
    Nephrol Dial Transplant; 2020 Jun; 35(6):979-986. PubMed ID: 32227227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
    De Vecchi AF; Dratwa M; Wiedemann ME
    Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis Care and Dialysis Funding in Asia.
    Tang SCW; Yu X; Chen HC; Kashihara N; Park HC; Liew A; Goh BL; Nazareth MGC; Bunnag S; Tan J; Lun V; Lydia A; Sharma SK; Hoque E; Togtokh A; Ghnaimet M; Jha V
    Am J Kidney Dis; 2020 May; 75(5):772-781. PubMed ID: 31699518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.
    Zhang H; Zhang C; Zhu S; Ye H; Zhang D
    BMC Health Serv Res; 2020 Feb; 20(1):122. PubMed ID: 32059726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality in end-stage renal disease: a reassessment of differences between patients treated with hemodialysis and peritoneal dialysis.
    Vonesh EF; Moran J
    J Am Soc Nephrol; 1999 Feb; 10(2):354-65. PubMed ID: 10215336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
    Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal disease.
    Berger A; Edelsberg J; Inglese GW; Bhattacharyya SK; Oster G
    Am J Manag Care; 2009 Aug; 15(8):509-18. PubMed ID: 19670954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of economies of scale in the cost of dialysis across the world: a macroeconomic perspective.
    Karopadi AN; Mason G; Rettore E; Ronco C
    Nephrol Dial Transplant; 2014 Apr; 29(4):885-92. PubMed ID: 24516226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease.
    Ganesh SK; Hulbert-Shearon T; Port FK; Eagle K; Stack AG
    J Am Soc Nephrol; 2003 Feb; 14(2):415-24. PubMed ID: 12538742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease.
    Couchoud C; Couillerot AL; Dantony E; Elsensohn MH; Labeeuw M; Villar E; Ecochard R; Bongiovanni I
    Nephrol Dial Transplant; 2015 Dec; 30(12):2054-68. PubMed ID: 26268714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
    Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
    BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
    Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
    BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis.
    Vonesh EF; Snyder JJ; Foley RN; Collins AJ
    Kidney Int; 2004 Dec; 66(6):2389-401. PubMed ID: 15569331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines.
    Bayani DBS; Almirol BJQ; Uy GDC; Taneo MJS; Danguilan RS; Arakama MI; Lamban AB; de Leon D; Pamugas GEP; Luz AC; Teerawatananon Y
    Nephrology (Carlton); 2021 Feb; 26(2):170-177. PubMed ID: 33207027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
    Shih YC; Guo A; Just PM; Mujais S
    Kidney Int; 2005 Jul; 68(1):319-29. PubMed ID: 15954923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of initial dialysis modality on mortality: a propensity-matched study.
    Waldum-Grevbo B; Leivestad T; Reisæter AV; Os I
    BMC Nephrol; 2015 Oct; 16():179. PubMed ID: 26519164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.